Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:INBSNASDAQ:MHUANASDAQ:POAIOTCMKTS:VYCO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINBSIntelligent Bio Solutions$1.49+0.7%$1.33$1.00▼$3.00$10.30M4.63550,120 shs51,681 shsMHUAMeihua International Medical Technologies$0.48+17.1%$0.33$0.25▼$1.47$12.04M0.48678,399 shs945,618 shsPOAIPredictive Oncology$0.91+1.1%$1.11$0.55▼$3.06$8.13M1.31.94 million shs112,899 shsVYCOVycor Medical$0.11+6.6%$0.10$0.03▼$0.50$3.56M0.1115,609 shs8,300 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINBSIntelligent Bio Solutions+4.96%+17.93%+15.63%-26.73%-36.21%MHUAMeihua International Medical Technologies+3.36%+10.62%+43.66%+27.11%-38.82%POAIPredictive Oncology0.00%-16.97%-14.62%-34.89%-56.59%VYCOVycor Medical-22.12%-16.84%+33.16%+45.14%+11.11%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINBSIntelligent Bio Solutions0.3654 of 5 stars0.02.00.00.02.70.00.6MHUAMeihua International Medical Technologies1.6601 of 5 stars0.05.00.00.03.01.70.6POAIPredictive Oncology2.5874 of 5 stars3.05.00.00.02.50.01.3VYCOVycor MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINBSIntelligent Bio Solutions 0.00N/AN/AN/AMHUAMeihua International Medical Technologies 0.00N/AN/AN/APOAIPredictive Oncology 2.00Hold$3.00229.67% UpsideVYCOVycor Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINBSIntelligent Bio Solutions$2.94M3.51N/AN/A$0.80 per share1.86MHUAMeihua International Medical Technologies$96.91M0.12$0.70 per share0.69$6.13 per share0.08POAIPredictive Oncology$1.73M4.70N/AN/A$2.04 per share0.45VYCOVycor Medical$1.46M2.44N/AN/A($0.10) per share-1.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINBSIntelligent Bio Solutions-$10.16MN/A0.004.26N/A-323.79%-146.03%-83.62%N/AMHUAMeihua International Medical Technologies$11.62MN/A0.00∞N/AN/AN/AN/AN/APOAIPredictive Oncology-$13.98M-$3.05N/AN/AN/A-1,012.32%-286.30%-122.11%8/12/2025 (Estimated)VYCOVycor Medical-$70KN/A0.00∞N/A-13.46%N/A-18.94%8/11/2025 (Estimated)Latest VYCO, POAI, INBS, and MHUA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025VYCOVycor MedicalN/A-$0.01N/A-$0.01N/A$0.44 million5/14/2025Q1 2025POAIPredictive Oncology-$0.09-$0.32-$0.23-$0.34$1.50 million$0.11 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/APOAIPredictive OncologyN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINBSIntelligent Bio SolutionsN/A0.920.76MHUAMeihua International Medical TechnologiesN/A4.784.74POAIPredictive OncologyN/A1.201.06VYCOVycor MedicalN/A0.160.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINBSIntelligent Bio Solutions32.97%MHUAMeihua International Medical Technologies1.17%POAIPredictive Oncology9.04%VYCOVycor MedicalN/AInsider OwnershipCompanyInsider OwnershipINBSIntelligent Bio Solutions1.54%MHUAMeihua International Medical Technologies66.56%POAIPredictive Oncology3.44%VYCOVycor Medical7.03%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINBSIntelligent Bio Solutions106.91 million5.26 millionNot OptionableMHUAMeihua International Medical Technologies62025.08 million8.39 millionNot OptionablePOAIPredictive Oncology308.93 million6.44 millionNot OptionableVYCOVycor Medical633.42 million30.32 millionNot OptionableVYCO, POAI, INBS, and MHUA HeadlinesRecent News About These CompaniesVycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 14, 2025 | finance.yahoo.comEQS-News: Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 13, 2025 | markets.businessinsider.comMedical ethics articles from across Nature PortfolioOctober 22, 2024 | nature.comBlueChew Review 2024January 17, 2024 | medicalnewstoday.comWhat to know about bleeding hemorrhoidsDecember 19, 2023 | medicalnewstoday.comCommon symptoms of depression: What to knowOctober 11, 2023 | medicalnewstoday.comVycor Medical, Inc. (VYCO)January 7, 2023 | finance.yahoo.comMedical Review BoardNovember 1, 2022 | health.usnews.comMedical Scholars ProgramSeptember 12, 2022 | slu.eduVycor Medical IncSeptember 8, 2022 | reuters.comMinnetronix commercializes its own product: a minimally invasive deep brain access portAugust 20, 2022 | medcitynews.comViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMay 12, 2022 | nice.org.ukVycor Medical Year to Date Total Returns (Daily)January 2, 2022 | ycharts.comVycor Medical Inc (VYCO)December 17, 2021 | nasdaq.comThe journal of physical chemistry. BOctober 18, 2021 | medscape.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVYCO, POAI, INBS, and MHUA Company DescriptionsIntelligent Bio Solutions NASDAQ:INBS$1.49 +0.01 (+0.68%) Closing price 04:00 PM EasternExtended Trading$1.50 +0.01 (+0.34%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Meihua International Medical Technologies NASDAQ:MHUA$0.48 +0.07 (+17.07%) Closing price 03:59 PM EasternExtended Trading$0.47 -0.01 (-2.29%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Predictive Oncology NASDAQ:POAI$0.91 +0.01 (+1.11%) Closing price 04:00 PM EasternExtended Trading$0.90 -0.01 (-1.32%) As of 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.Vycor Medical OTCMKTS:VYCO$0.11 +0.01 (+6.60%) As of 01:44 PM EasternVycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
